Attention West Virginia Medicaid Pharmacy Providers! Paxlovid Billing Update is now available!
1/2/2024
Page Content
In October 2023, Pfizer and the US Department of Health and Human Services (HHS), reached an agreement to extend patient access to the COVID-19 oral antiviral medication, Paxlovid, for individuals receiving Medicaid, Medicare and those are who are uninsured through the end of 2024. On December 1, 2023, Pfizer launched its US Government Patient Assistance (USG PAP), PAXCESS Patient Support Program. Patients, caregivers, and healthcare professionals, including pharmacists, may enroll patients by visiting the PAXCESS Patient Support Program website or calling 877-C19-PACK (877-219-7225).
For dates of service beginning December 28, 2023, all West Virginia Medicaid pharmacy claims for commercially available Paxlovid products will be reimbursed in the same manner as other covered outpatient drugs. For more detailed information, please click on the memo below.
West Virginia Medicaid Paxlovid Billing Memo
Contact Information
For more information, please contact the Bureau for Medical Services (BMS) at 304-558-1700.